| Ytd | -12.79% | |
| 1y | -35.02% |
| Open | 1.30 | Prev Close | 1.32 | Low | 1.28 | High | 1.30 | Mkt Cap | 6.28M |
| Vol | 25.27K | Avg Vol | 122.21K | EPS | -0.05 | P/E | -26.40 | Forward P/E | N/A |
| Beta | -1.12 | Short Ratio | 0.17 | Inst. Own | 1.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.17 | 200-d Avg | 1.66 | 1yr Est | 0.00 |
SINGAPORE, July 15, 2026 (GLOBE NEWSWIRE) -- JBDI Holdings Limited (Nasdaq: JBDI) today announced th
Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial